Get the Stockscreener App
63.41
0.52%
-0.33
After Hours:
63.00
-0.41
-0.65%
Centene Corp stock is traded at $63.41, with a volume of 2.81M.
It is down -0.52% in the last 24 hours and up +0.70% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$63.74
Open:
$64.19
24h Volume:
2.81M
Relative Volume:
0.51
Market Cap:
$31.31B
Revenue:
$198.10B
Net Income/Loss:
$-6.45B
P/E Ratio:
-4.8241
EPS:
-13.1443
Net Cash Flow:
$7.11B
1W Performance:
-4.56%
1M Performance:
+0.70%
6M Performance:
+37.58%
1Y Performance:
+136.96%
1-Day Range:
$62.97
$64.60
1-Week Range:
$62.86
$67.64
52-Week Range:
$25.07
$69.36
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
63.41 | 31.31B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
420.74 | 382.09B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
107.74 | 137.47B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.68 | 81.91B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
289.57 | 76.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.32 | 46.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-14-25 | Initiated | Goldman | Sell |
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
CNC|Centene Corp|Price:63.410|Chg%:-0.330 - TradingKey
Centene stock holds steady as Medicaid membership and revenue guidance frame investor focus - AD HOC NEWS
Centene stock remains anchored by Medicaid scale and earnings - AD HOC NEWS
Ex-Centene VP claims company used records access as pretext to replace her with younger hire - The Business Journals
Centene stock trades with earnings pressure and Medicaid shifts - AD HOC NEWS
Is Centene Corp (CNC) a Bargain After 3.3% Drop? GF Value Says U - GuruFocus
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Centene (CNC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
CNC|Centene Corp|Price:63.740| - TradingKey
Centene stock trades steady as Medicaid membership and earnings shape outlook - AD HOC NEWS
Centene Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Centene accused of age discrimination by ousted VP - STLtoday.com
Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates - Yahoo Finance
Centene stock reflects managed care earnings power as Medicaid shift continues - AD HOC NEWS
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene stock trades steady as Medicaid membership returns to growth - AD HOC NEWS
Cognizant Lands Centene Mega Deal Worth Over $500 Mn: Report - analyticsindiamag.com
Cognizant Wins Multi-Year Centene Deal That Could Touch $1 Billion - outlookbusiness.com
Cognizant bags over $500 million Centene deal, deepens AI push in healthcare - Storyboard18
Cognizant bags mega deal from Centene, likely worth over $500 million - Moneycontrol.com
Smart Money Is Buying Centene Corp. (CNC) - The Acquirer's Multiple
Centene (NYSE: CNC) grants 3,155 restricted stock units to director Tyler - Stock Titan
Centene stock trades steady as Medicaid and marketplace growth shapes 2026 outlook - AD HOC NEWS
Centene stock trades steady as Medicaid and marketplace membership support recent earnings momentum - AD HOC NEWS
Centene stock reflects its latest earnings and market backdrop. - Ad-hoc-news.de
Centene Corp (CNC) Shares Surge 4.0% -- What GF Score of 73 Tells Investors - GuruFocus
Centene Corporation’s Stock Price Soars to $66.44, Marking a Robust 3.99% Increase - Smartkarma
Why Centene (CNC) Stock Is Up Today - Quiver Quantitative
Centene stock holds near health insurance peers after latest earnings - ad-hoc-news.de
Centene Beats 401(k) Suit Over Collective Trusts, Forfeitures - Bloomberg Law News
Arkansas Explained: What’s happening to the state’s Medicaid expansion? - Arkansas Advocate
Lobbying Update: $30,000 of CENTENE CORPORATIONS lobbying was just disclosed - Quiver Quantitative
Centene (CNC) Stock Sees Modest Fair Value Lift As Analysts Back Earnings Recovery - Yahoo Finance
What's Behind Centene's Recent Stock Plunge - Kavout | AI
Is Centene Corp (CNC) a Bargain After 3.1% Drop? GF Value Says U - GuruFocus
Why is Centene stock sliding today? - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Centene stock holds steady as managed care strategy targets Medicaid and marketplace growth - Ad-hoc-news.de
Publicly held genetic testing firm sues Centene, alleging prenatal test reimbursement scheme - The Business Journals
Centene Corp stock hits 52-week high at 69.35 USD By Investing.com - Investing.com South Africa
Centene Stock Soars 66% YTD: Should Investors Chase the Rally? - Yahoo Finance
CNC Maintained by TD Cowen -- Price Target Raised to $65 - GuruFocus
Centene Corp stock hits 52-week high at 69.35 USD - Investing.com
Centene Corporation (CNC) Rallied Following the Robust Result - Yahoo Finance
CNC Maintained by Wells Fargo -- Price Target Raised to $69.00 - GuruFocus
Centene stock reflects steady managed care positioning amid US healthcare policy shifts - ad-hoc-news.de
Centene (CNC) Stock May Still Be A Bargain After A 114% Run - Yahoo Finance
Daily Brief Health Care: Centene Corp, FibroBiologics, Molina Healthcare, Solvonis Therapeutics and more - Smartkarma
Centene (CNC) Joins Growth Indexes On A Narrative That May Already Be Priced In - Yahoo Finance
Centene Corporation to release Q2FY26 results on July 28 - scanx.trade
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):